CMIT researchers are pinpointing bacterial species that trigger the development of special immune cells which may be protective against ulcerative colitis and other inflammatory disorders.
CMIT researchers and their collaborators have figured out how to circumvent those obstacles and enhance our understanding of the invisible communities in our guts.
The Center for Microbiome Informatics and Therapeutics joined the New England Chapter of Crohn’s and Colitis Foundation for their annual spin4 crohn’s and colitis cures fundraiser
When the Covid-19 pandemic was declared, both current and former members of the Alm lab jumped into action to help communities stay ahead of local case surges.
A new study from an MIT-led team has revealed that these bacterial populations can remake themselves within the lifetime of their host, by passing genes back and forth.
In a recent study, researchers use single cell sequencing of intestinal tissue biopsies from diseased and healthy patients to create a cell atlas that lends novel insight into the cellular pathways that link implicated genes to UC pathophysiology.
Fecal Microbiota Transplant (FMT) is gaining traction as a potentially effect treatment of the increasing number of diseases that have been linked to microbiome dysbiosis.